Medtronic Lays Out Plans To Achieve 5%+ Annual Growth
Executive Summary
The medtech giant offered additional details on its ongoing restructuring plan intended to make the company more competitive.
You may also be interested in...
JPM 2021: Medtronic, Biogen, Edwards LifeSciences, Guardant Health, Illumina
The annual J.P. Morgan Healthcare Conference includes presentations from many major medtech companies outlining their growth strategies and expectations for 2021. Here are some of the highlights from the first day of the meeting.
Medtronic Cardiovascular Chief Coyle To Lead iRhythm
Sean Salmon, the head of Medtronic’s diabetes business, will take over the leadership of the company’s cardiovascular business effective 1 January.
Medtronic Expands ENT Portfolio With Ai Biomed Acquisition, NIM Vital Clearance
Ai Biomed’s PTeye helps to identify parathyroid tissue during thyroid surgery. Medtronic ENT also announced the FDA clearance of its NIM Vital electromyographic system for nerve monitoring during surgery.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: